ARCHIVES

NCI’s SBIR Paylines Nears Regular Grants

This article is from The Cancer Letter archive.

Vol. 11 No. 36 | September 20, 1985

Download PDF Visit The Full Archive

Related Articles

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

Gottlieb questions ODAC’s independence.

August 5, 2005

Regulatory Policy: Bush To Seek Legislation For Pediatric Drug Tests.

January 3, 2003